Hemoglobin A1c Levels Are Slightly but Significantly Lower in Normoglycemic Subjects With the Hemoglobin E Phenotype

• Published in: Annals of laboratory medicine Vol. 39; no. 2; pp. 209 - 213
• Main Authors: Pratumvinit, Busadee, Reesukumal, Kanit, Hanyongyuth, Sithikan, Wangchaijaroenkit, Sujitra, Pooliam, Julaporn, Kost, Gerald J., Kamkang, Panumas, Loh, Tze Ping
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Society for Laboratory Medicine 01.03.2019; 대한진단검사의학회
• Subjects: Brief Communication; 병리학; Immunoassay; Hemoglobin A1c; Hemoglobin E; HPLC
• ISSN: 2234-3806; 2234-3814; 2234-3814
• DOI: 10.3343/alm.2019.39.2.209

Hb mutations can alter the structure, behavior, stability, or quantity of the globin chain produced. Some Hb variants shorten the erythrocyte life span, resulting in physiologically lower hemoglobin A1c (HbA1c) levels. The hemoglobin E (HbE) phenotype involves a single-nucleotide polymorphism that reduces β-globin chain synthesis. We compared the HbA1c levels of subjects with normal Hb (HbAA; N=131) and HbE (N=148) phenotypes, examining potential hematological and biochemical factors contributing to differences in HbA1c levels. All had normal fasting plasma glucose (<5.6 mmol/L), AST, ALT, and creatinine levels. Mean±SD HbA1c levels differed between HbAA and HbE subjects: 5.5±0.3% and 5.3±0.3% ( <0.001) according to an immunoassay, and 5.5±0.3% and 5.3±0.3% ( <0.001) according to cation-exchange HPLC, respectively. In multiple logistic regression, only mean corpuscular volume ( <0.001) contributed to the difference in HbA1c levels between groups. Although a 0.2% difference in HbA1c is relatively small and unlikely to alter clinical decisions, epidemiologically, this can lead to misclassification of a significant proportion of the population, especially since the threshold of non-diabetes HbA1c (≤5.6%) falls very close to the HbA1c median of the general population.